John Fung to Time Factors
This is a "connection" page, showing publications John Fung has written about Time Factors.
Connection Strength
1.497
-
Limitations of current liver transplant immunosuppressive regimens: renal considerations. Hepatobiliary Pancreat Dis Int. 2017 Feb; 16(1):27-32.
Score: 0.079
-
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation. 2017 Feb; 101(2):341-349.
Score: 0.079
-
Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. HPB (Oxford). 2011 Sep; 13(9):651-5.
Score: 0.054
-
Robotic versus laparoscopic resection of liver tumours. HPB (Oxford). 2010 Oct; 12(8):583-6.
Score: 0.051
-
Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl. 2009 Sep; 15(9):1003-6.
Score: 0.047
-
Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl. 2008 Oct; 14(10):1406-11.
Score: 0.044
-
Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl. 2007 Dec; 13(12):1633-6.
Score: 0.042
-
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation. 2005 Dec 27; 80(12):1692-8.
Score: 0.037
-
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation. 2005 Sep 27; 80(6):859-64.
Score: 0.036
-
Alcoholic liver disease and transplantation. Transplant Proc. 2003 Feb; 35(1):358-60.
Score: 0.030
-
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
Score: 0.029
-
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Transplantation. 2001 Apr 27; 71(8):1102-6.
Score: 0.026
-
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol. 2001 Mar; 41(3):268-76.
Score: 0.026
-
Understanding and preventing late graft loss. Transplant Proc. 2000 Nov; 32(7):1514.
Score: 0.026
-
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000 Oct; 232(4):490-500.
Score: 0.025
-
Early Infectious Complications After Total Pancreatectomy with Islet Autotransplantation: a Single Center Experience. J Gastrointest Surg. 2019 11; 23(11):2201-2210.
Score: 0.023
-
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc. 1999 Feb-Mar; 31(1-2):700-1.
Score: 0.023
-
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
Score: 0.022
-
Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. Exp Clin Transplant. 2018 08; 16(4):439-445.
Score: 0.022
-
A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures. HPB (Oxford). 2018 09; 20(9):829-833.
Score: 0.021
-
Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl. 2018 02; 24(2):233-245.
Score: 0.021
-
Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc. 1997 Jun; 29(4):2263-4.
Score: 0.020
-
Hemophilia Liver Transplantation Observational Study. Liver Transpl. 2017 06; 23(6):762-768.
Score: 0.020
-
Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017 Jun; 16(3):264-270.
Score: 0.020
-
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
Score: 0.020
-
Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation. 1996 Dec 15; 62(11):1584-7.
Score: 0.020
-
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015 Jul; 99(7):1455-62.
Score: 0.018
-
Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Liver Transpl. 2015 Jan; 21(1):101-11.
Score: 0.017
-
The effect of splenectomy on cardiac and liver xenografts in the nude rat. Transplant Proc. 1994 Jun; 26(3):1210.
Score: 0.016
-
Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol. 2014 Jun; 29(6):1250-7.
Score: 0.016
-
Human islet allograft follow-up: long-term islet function and over 3 years of insulin independence. Transplant Proc. 1994 Apr; 26(2):569.
Score: 0.016
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.016
-
Infectious complications after human small bowel transplantation. Transplant Proc. 1992 Jun; 24(3):1249-50.
Score: 0.014
-
Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford). 2012 May; 14(5):325-32.
Score: 0.014
-
Hepatic blood flow plays an important role in ischemia-reperfusion injury. Liver Transpl. 2011 Dec; 17(12):1448-56.
Score: 0.014
-
Liver transplantation at Cleveland Clinic. Clin Transpl. 2010; 195-206.
Score: 0.012
-
Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol. 1990; 14 Suppl 1:49-63.
Score: 0.012
-
World's longest surviving liver-pancreas recipient. Liver Transpl. 2007 Jul; 13(7):957-60.
Score: 0.010
-
ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation. Microsurgery. 2007; 27(4):328-32.
Score: 0.010
-
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant. 2006 Dec; 6(12):2983-93.
Score: 0.010
-
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006 Aug; 44(2):489-501.
Score: 0.010
-
Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int. 2006 Jan; 19(1):27-37.
Score: 0.009
-
Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation. J Clin Pharmacol. 2005 Jun; 45(6):666-73.
Score: 0.009
-
Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc. 2004 Sep; 36(7):1955-8.
Score: 0.008
-
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation. 2003 Nov 27; 76(10):1487-91.
Score: 0.008
-
Ex vivo priming of naïve T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL. Am J Transplant. 2003 Nov; 3(11):1369-77.
Score: 0.008
-
Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts. Am J Transplant. 2003 Sep; 3(9):1173-81.
Score: 0.008
-
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol. 2002 Aug; 104(2):138-50.
Score: 0.007
-
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc. 2002 Aug; 34(5):1651-2.
Score: 0.007
-
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc. 2002 Aug; 34(5):1955-7.
Score: 0.007
-
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc. 2002 Aug; 34(5):1968-9.
Score: 0.007
-
Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
Score: 0.007
-
Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002 Mar; 2(3):287-91.
Score: 0.007
-
Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today. 2002; 32(9):792-9.
Score: 0.007
-
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant. 2001 May; 1(1):47-50.
Score: 0.007
-
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
Score: 0.007
-
Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc. 2001 Feb-Mar; 33(1-2):1134-5.
Score: 0.006
-
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 2000 Sep 15; 70(5):760-4.
Score: 0.006
-
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
Score: 0.006
-
The long-term efficacy of multivisceral transplantation. Transplant Proc. 2000 Sep; 32(6):1219-20.
Score: 0.006
-
Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc. 2000 Sep; 32(6):1223-4.
Score: 0.006
-
Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. Transplant Proc. 2000 Aug; 32(5):1032-3.
Score: 0.006
-
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation. 2000 Feb 15; 69(3):383-8.
Score: 0.006
-
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation. 2000 Jan 27; 69(2):265-71.
Score: 0.006
-
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
Score: 0.006
-
Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg. 1999 Apr-Jun; 62(2):244-7.
Score: 0.006
-
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
Score: 0.006
-
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. Transplant Proc. 1999 Feb-Mar; 31(1-2):488-9.
Score: 0.006
-
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
Score: 0.006
-
Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation. 1999 Jan 27; 67(2):266-72.
Score: 0.006
-
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. Clin Transpl. 1999; 217-21.
Score: 0.006
-
Long-term nutritional monitoring after clinical intestinal transplantation. Transplant Proc. 1998 Sep; 30(6):2515-6.
Score: 0.005
-
Nutritional management of intestinal allograft recipients. Transplant Proc. 1998 Sep; 30(6):2517-8.
Score: 0.005
-
Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc. 1998 Jun; 30(4):1367-8.
Score: 0.005
-
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1375-7.
Score: 0.005
-
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther. 1998 Mar; 63(3):296-302.
Score: 0.005
-
Current status of intestinal transplantation in children. J Pediatr Surg. 1998 Feb; 33(2):243-54.
Score: 0.005
-
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
Score: 0.005
-
Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc. 1997 Dec; 29(8):3731-2.
Score: 0.005
-
HLA and cross-reactive antigen group matching for cadaver kidney allocation. Transplantation. 1997 Oct 15; 64(7):983-91.
Score: 0.005
-
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
Score: 0.005
-
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997 Aug; 26(2):444-50.
Score: 0.005
-
Central venulitis in the allograft liver: a clinicopathologic study. Transplantation. 1997 Jul 27; 64(2):252-7.
Score: 0.005
-
Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. Transplant Proc. 1997 Jun; 29(4):2175-6.
Score: 0.005
-
An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc. 1997 Jun; 29(4):2238-9.
Score: 0.005
-
Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):306.
Score: 0.005
-
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):310.
Score: 0.005
-
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1174-7.
Score: 0.005
-
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1184-5.
Score: 0.005
-
Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):928-9.
Score: 0.005
-
Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
Score: 0.005
-
Gastrointestinal bleeding after liver transplantation. Transplantation. 1997 Jan 15; 63(1):60-7.
Score: 0.005
-
Tacrolimus in renal transplantation. Transplant Proc. 1996 Aug; 28(4):2117-8.
Score: 0.005
-
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis. 1996 May; 173(5):1072-6.
Score: 0.005
-
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. Transplant Proc. 1996 Apr; 28(2):735.
Score: 0.005
-
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. Transplant Proc. 1996 Apr; 28(2):736-7.
Score: 0.005
-
Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995 Dec; 22(6):1754-62.
Score: 0.005
-
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol. 1995 Nov; 2(6):483-7.
Score: 0.005
-
Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc. 1995 Oct; 27(5):2898.
Score: 0.004
-
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc. 1995 Apr; 27(2):1862-7.
Score: 0.004
-
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
Score: 0.004
-
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc. 1995 Feb; 27(1):814-7.
Score: 0.004
-
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol. 1995 Feb; 19(2):192-206.
Score: 0.004
-
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc. 1995 Feb; 27(1):207-9.
Score: 0.004
-
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
Score: 0.004
-
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation. 1995 Jan 27; 59(2):212-7.
Score: 0.004
-
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. Transplant Proc. 1994 Jun; 26(3):1208.
Score: 0.004
-
Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection. Transplant Proc. 1994 Jun; 26(3):1288-9.
Score: 0.004
-
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation. 1994 Jan; 57(1):149-51.
Score: 0.004
-
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994 Jan; 219(1):40-5.
Score: 0.004
-
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993 Oct; 177(4):335-44.
Score: 0.004
-
Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug; 56(2):482-4.
Score: 0.004
-
Posttransplant hypertension in blacks versus nonblacks. Transplant Proc. 1993 Aug; 25(4):2456-7.
Score: 0.004
-
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc. 1993 Jun; 25(3):2381-5.
Score: 0.004
-
Long-term survival of heart and liver xenografts with splenectomy and FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 1):647-8.
Score: 0.004
-
Intestinal transplantation in humans under FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 2):1198-9.
Score: 0.004
-
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. Transplant Proc. 1991 Dec; 23(6):2873-4.
Score: 0.003
-
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3269-71.
Score: 0.003
-
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 1991 Apr; 13(4):619-26.
Score: 0.003
-
The liver transplant waiting list--a single-center analysis. Transplantation. 1991 Jan; 51(1):128-34.
Score: 0.003
-
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation. 1988 Sep; 46(3):372-7.
Score: 0.003
-
Effect of OKT3 on survival and rate of retransplantation. Transplant Proc. 1987 Aug; 19(4 Suppl 3):61-2.
Score: 0.003